Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-contact Daivobet Gel in Psoriasis
NCT01607853Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Jun 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of calcipotriol + betamethasone in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Primary endpoint: Change in Total Clinical Score From Baseline at Day 22. Started Jun 2012; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT01607853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01607853.